Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

CHEMBO MEDICO ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   1.8% 1.8% 1.8% 1.8% 1.8% 1.8% 1.8% 1.8%   Bankruptcy risk   6.7% 5.7% 4.0% 3.4% 2.9% 5.9% 11.0% 10.8%   Credit score (0-100)   37 41 50 53 58 38 22 23   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   23.0 122 73.7 117 291 38.5 0.0 0.0   EBITDA   23.0 122 73.7 117 291 38.5 0.0 0.0   EBIT   23.0 122 70.3 103 278 28.3 0.0 0.0   Pre-tax profit (PTP)   22.9 121.7 70.2 102.3 277.4 109.9 0.0 0.0   Net earnings   17.9 94.9 54.8 79.8 216.4 85.6 0.0 0.0   Pre-tax profit without non-rec. items   22.9 122 70.2 102 277 110 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 37.3 23.8 10.2 0.0 0.0 0.0   Shareholders equity total   585 680 734 814 1,031 1,116 616 616   Interest-bearing liabilities   468 449 476 497 647 600 0.0 0.0   Balance sheet total (assets)   1,092 1,228 1,274 1,342 1,743 1,743 616 616   Net Debt   468 441 340 407 647 542 -616 -616     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   23.0 122 73.7 117 291 38.5 0.0 0.0   Gross profit growth   9.2% 429.7% -39.5% 58.8% 148.9% -86.8% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,092 1,228 1,274 1,342 1,743 1,743 616 616   Balance sheet change%   4.7% 12.4% 3.8% 5.3% 29.9% -0.0% -64.6% 0.0%   Added value   23.0 121.8 73.7 117.0 291.2 38.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 34 -27 -27 -20 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 100.0% 95.4% 88.4% 95.3% 73.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   2.2% 10.5% 5.6% 7.9% 18.0% 6.4% 0.0% 0.0%   ROI %   2.2% 11.2% 6.0% 8.2% 18.5% 6.6% 0.0% 0.0%   ROE %   3.1% 15.0% 7.8% 10.3% 23.5% 8.0% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   53.5% 55.4% 57.6% 60.7% 59.1% 64.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   2,034.6% 361.7% 461.7% 347.6% 222.0% 1,407.7% 0.0% 0.0%   Gearing %   80.0% 66.1% 64.8% 61.0% 62.7% 53.8% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.1% 0.0% 0.1% 0.2% 0.0% 0.3% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   1.5 2.0 2.1 2.2 2.2 2.6 0.0 0.0   Current Ratio   2.2 2.2 2.3 2.5 2.4 2.8 0.0 0.0   Cash and cash equivalent   0.0 8.7 136.1 90.2 0.0 58.7 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   584.8 679.7 705.4 795.8 1,022.7 1,116.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0